Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic ...

A generic product cannot enter the market until the originator product’s IP has expired, but the development process can take ...

If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.

Health analysts and generic drug manufacturers said the 20% levy from two rounds of tariffs on goods imported from China − a major supplier of medical equipment and prescription drugs for the ...

Hint: It's all in the suffix. Viagra, Prozac, Xanax, and Zoloft all went through a process to select memorable names.

Between 2005 and 2015, nearly three-fourths of issued drug patents were for already existing drugs. A common argument in ...

A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...

A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared ...